Full article available to subscribers
The case report by Dr Jayathissa and Dr Dee published in the 23 September 2011 issue of the Journalis an important reminder of the potential dangers even small bore chest drains can pose to patients.1In recent years the availability of Seldinger chest drains has seen a move away from large bore tubes inserted by blunt dissection. While this is generally considered to be a positive thing for our patients, one might question whether their relative ease of insertion has led to them being overused by junior staff.In general terms there are only three indications for the insertion of an indwelling chest tube, whatever the size: treatment of pneumothorax where aspiration has failed; management of pleural infection or empyema; and when the intention of draining the fluid is to perform a medical pleurodesis.In almost all other clinical scenarios, including the one in the case presented, if the goal is to relieve dyspnoea then a simple thoracocentesis is all that is required. Whether this is done using an intravenous cannula, or a pre-packed thoracocentesis kit, the risk of complications is much lower than with drain insertion.Even in patients with large effusions, the aspiration of just a litre of fluid is usually enough to make them more comfortable. The authors have thoroughly highlighted all the key features associated with the safe insertion of chest drains, but I would also emphasise an even earlier decision: is a chest drain required at all?Kyle Perrin Respiratory Physician Capital and Coast District Health Board Wellington
- Jayathissa S, Dee S. How safe is the safe triangle? N Z Med J. 124(1343).-
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz